Belykh Evgenii, Miller Eric J, Hu Danying, Martirosyan Nikolay L, Woolf Eric C, Scheck Adrienne C, Byvaltsev Vadim A, Nakaji Peter, Nelson Leonard Y, Seibel Eric J, Preul Mark C
Department of Neurosurgery, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona, USA; Department of Neurosurgery, Irkutsk State Medical University, Irkutsk, Russia.
Department of Neurosurgery, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona, USA.
World Neurosurg. 2018 May;113:e51-e69. doi: 10.1016/j.wneu.2018.01.151. Epub 2018 Feb 2.
Fluorescence-guided surgery with protoporphyrin IX (PpIX) as a photodiagnostic marker is gaining acceptance for resection of malignant gliomas. Current wide-field imaging technologies do not have sufficient sensitivity to detect low PpIX concentrations. We evaluated a scanning fiber endoscope (SFE) for detection of PpIX fluorescence in gliomas and compared it to an operating microscope (OPMI) equipped with a fluorescence module and to a benchtop confocal laser scanning microscope (CLSM).
5-Aminolevulinic acid-induced PpIX fluorescence was assessed in GL261-Luc2 cells in vitro and in vivo after implantation in mouse brains, at an invading glioma growth stage, simulating residual tumor. Intraoperative fluorescence of high and low PpIX concentrations in normal brain and tumor regions with SFE, OPMI, CLSM, and histopathology were compared.
SFE imaging of PpIX correlated to CLSM at the cellular level. PpIX accumulated in normal brain cells but significantly less than in glioma cells. SFE was more sensitive to accumulated PpIX in fluorescent brain areas than OPMI (P < 0.01) and dramatically increased imaging time (>6×) before tumor-to-background contrast was diminished because of photobleaching.
SFE provides new endoscopic capabilities to view PpIX-fluorescing tumor regions at cellular resolution. SFE may allow accurate imaging of 5-aminolevulinic acid labeling of gliomas and other tumor types when current detection techniques have failed to provide reliable visualization. SFE was significantly more sensitive than OPMI to low PpIX concentrations, which is relevant to identifying the leading edge or metastasizing cells of malignant glioma or to treating low-grade gliomas. This new application has the potential to benefit surgical outcomes.
以原卟啉 IX(PpIX)作为光诊断标志物的荧光引导手术在恶性胶质瘤切除术中越来越被认可。当前的宽视野成像技术对低浓度 PpIX 的检测灵敏度不足。我们评估了一种扫描光纤内窥镜(SFE)用于检测胶质瘤中的 PpIX 荧光,并将其与配备荧光模块的手术显微镜(OPMI)以及台式共聚焦激光扫描显微镜(CLSM)进行比较。
在体外培养的 GL261 - Luc2 细胞中以及将其植入小鼠脑内后处于侵袭性胶质瘤生长阶段(模拟残留肿瘤)时,评估 5 - 氨基酮戊酸诱导的 PpIX 荧光。比较了在正常脑区和肿瘤区域中使用 SFE、OPMI、CLSM 检测高、低浓度 PpIX 时的术中荧光情况以及组织病理学结果。
在细胞水平上,SFE 对 PpIX 的成像与 CLSM 相关。PpIX 在正常脑细胞中积累,但明显少于胶质瘤细胞。SFE 对荧光脑区中积累的 PpIX 比 OPMI 更敏感(P < 0.01),并且在因光漂白导致肿瘤与背景对比度降低之前,成像时间显著增加(>6 倍)。
SFE 提供了新的内镜功能,能够以细胞分辨率观察 PpIX 荧光的肿瘤区域。当当前检测技术未能提供可靠的可视化时,SFE 可能允许对胶质瘤和其他肿瘤类型的 5 - 氨基酮戊酸标记进行准确成像。SFE 对低浓度 PpIX 的敏感性明显高于 OPMI,这与识别恶性胶质瘤的前沿或转移细胞或治疗低级别胶质瘤相关。这种新应用有可能改善手术效果。